BofA raised the firm’s price target on MetLife (MET) to $94 from $91 and keeps a Buy rating on the shares. Incorporating Q1 results into the firm’s model and updating projections, the firm’s forecasts rise from lower share count projections and higher earnings projections in Unum U.S., the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife’s Strategic Moves and Strong Group Benefits Performance Justify Buy Rating
- MetLife Reports Strong Q1 2025 Financial Results
- MetLife Announces $10 Billion Reinsurance Agreement
- MetLife reports Q1 adjusted EPS $1.96, consensus $2.00
- MetLife announces $10B variable annuity risk transfer transaction
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue